1 |
Husebye ES, Anderson MS. Autoimmune polyendocrine syndromes [J]. N Engl J Med, 2018, 378(12):1132-1141.
|
2 |
Houcken J, Degenhart C, Bender K, et al. PTPN22 and CTLA-4 polymorphisms are associated with polyglandular autoimmunity [J]. J Clin Endocrinol Metab, 2018, 103(5): 1977-1984.
|
3 |
滕晓春,单忠艳. 自身免疫性多内分泌腺综合征研究进展 [J]. 中国实用内科杂志, 2016, 36(9): 776.
|
4 |
Gunjur A, Klein O, Kee D. Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature [J]. J Immunother Cancer, 2019, 7(1): 241.
|
5 |
Yu L, Brewer KW, Gates S, et al. DRB104 and DQ Alleles: Expression of 21 hydroxylase autoantibodies and risk of progression to Addison′s disease [J]. J Clin Endocrinol Metab, 1999, 84(1):328-335.
|
6 |
Baschal EE, Aly TA, Babu SR, et al. HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population [J]. Diabetes, 2007, 56(9): 2405-2409.
|
7 |
Gupta AN, Nagri SK. Schmidt′s syndrome-case report [J]. Australas Med J, 2012, 5(6): 292-295.
|
8 |
Fourati H, Mahfoudh N, Abida O, et al. HLA-DRB1/DQB1 susceptibility for autoimmune polyglandular syndrome type II and III in south of Tunisia [J]. Ann Endocrinol (Paris), 2011, 72(3): 232-238.
URL
|
9 |
Kraus AU, Penna-Martinez M, Shoghi F, et al. HLA-DQB1 position 57 defines susceptibility to isolated and polyglandular autoimmunity in adults: interaction with gender [J]. J Clin Endocrinol Metab, 2019, 104(6): 1907-1916.
|
10 |
Hoener K. Type II polyglandular autoimmune syndrome: a case of Addison′s disease precipitated by use of levothyroxine [J]. BMJ Case Reports, 2019, 12(8): e230760.
|
11 |
Martins SC, Venade G, Teixeira M, et al. Autoimmune polyglandular syndrome type 2 [J]. Revista da Associação Médica Brasileira (1992), 2019, 65(12): 1434-1437.
|
12 |
Dave P, Bhosle D, Dharme M, et al. Autoimmune polyglandular syndrome type 2 with alopecia universalis and hypoparathyroidism [J]. J Assoc Physicians India, 2015, 63(4): 74-76.
|